AIP
NVO

Ahrens Investment Partners’s Novo Nordisk NVO Stock Holding History

Ahrens Investment Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$36K Buy
+452
New +$32.1K 0.02% 373
2022
Q3 		– Sell
-452
Closed -$25K – 659
2022
Q2 		$25K Hold
452
– – 0.01% 456
2022
Q1 		$25K Hold
452
– – 0.01% 542
2021
Q4 		$25K Buy
+452
New +$24.5K 0.01% 533

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Ahrens Investment Partners's NVO Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in Novo Nordisk (NVO) in Q1 2023: 452 shares worth $36K. The stake represents 0.02% of the portfolio and ranks #373 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in NVO as recently as Q2 2022.

Ahrens Investment Partners first reported a position in NVO in Q4 2021 and has held it in 4 quarters since. 1,146 funds tracked by Wall St. Rank hold NVO as of Q1 2023.

  • Ahrens Investment Partners held 452 shares of Novo Nordisk worth $36K as of Q1 2023.
  • Novo Nordisk was a new Ahrens Investment Partners position in Q1 2023.
  • Novo Nordisk made up 0.02% of Ahrens Investment Partners's portfolio in Q1 2023, its #373 holding.
  • Ahrens Investment Partners first reported a position in Novo Nordisk in Q4 2021 and has held it in 4 quarters since.
  • 1,146 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.